Cytokines and depression: The need for a new paradigm

This publication has 38 references indexed in Scilit:

• Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy
  Molecular Psychiatry, 2002
• Neurobehavioral Effects of Interferon-|[alpha]| in Cancer Patients: Phenomenology and Paroxetine Responsiveness of Symptom Dimensions
  Published by Springer Nature ,2002
• Treatment with interferon-alpha (IFNα) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFNα-induced depressive and anxiety symptoms and immune activation
  Molecular Psychiatry, 2001
• Effects of Antidepressant Drugs on the Behavioral and Physiological Responses to Lipopolysaccharide (LPS) in Rodents
  Neuropsychopharmacology, 2001
• Paroxetine for the Prevention of Depression Induced by High-Dose Interferon Alfa
  New England Journal of Medicine, 2001
• Clinical and Physiological Consequences of Rapid Tryptophan Depletion
  Neuropsychopharmacology, 2000
• The Corticosteroid Receptor Hypothesis of Depression
  Neuropsychopharmacology, 2000
• Olfactory Bulbectomy Provokes a Suppression of Interleukin-1β and Tumour Necrosis Factor-α Production in Response to an in vivo Challenge with Lipopolysaccharide: Effect of Chronic Desipramine Treatment
  Neuroimmunomodulation, 1999
• The Proinflammatory Cytokine, Interleukin-1 , Reduces Glucocorticoid Receptor Translocation and Function
  Endocrinology, 1999
• Cytokines and depression: fortuitous or causative association?
  Molecular Psychiatry, 1999